Hong Kong Stock Announcement Nuggets | Guichuang Tongqiao plans to indirectly take a stake in Xianjian Technology to establish a vascular intervention platform with a simultaneous premium of about 13.5% and increase the net raise of H shares by about HK$864 million

[Important matters]

Yuanxin Energy Storage (09621) Hong Kong's public sale received 1388.75 times the subscription and raised about HK$501.7 million from the global sale

Xianjian Technology (01302) plans to discount about 3.61% and issue 926 million subscription shares to raise about HK$1.47 billion

Guichuang Tongqiao (02190) plans to indirectly take a stake in Xianjian Technology (01302) to establish a vascular intervention platform at a simultaneous premium of about 13.5% and increase H shares with a net raise of about HK$864 million

Ruifeng Green Energy Computing (00527) plans to issue subscription shares to Winhui, Ruiyuan and Yuan Wanyong

China Biopharmaceutical (01177): TQ-A3334 “TLR7 agonist” releases phase II clinical data in 2026 AASLD

Jingtai Holdings (02228) collaborates with LABORATOIRES PIERRE FABRE for AI-driven drug discovery

Lai Kai Pharmaceutical-B (02105): LAE103 successfully completed phase I SAD study in overweight or obese subjects

Deshi-B (02526) and Yongjiang Laboratory signed a strategic cooperation agreement to jointly promote the application of large medical imaging models

Jinhai Medical Technology (02225) was acquired by Yang Fukang for 1,057 billion shares of the company, holding approximately 19.86% of the company's shares

Shandong Xinhua Pharmaceutical Co., Ltd. (00719) obtained the drug registration certificate for ketorolac and tromethotriol injection

Jiuyuan Gene (02566): JY54-2 injection IND application officially accepted by CDE

Shiyao Group (01093): Phase I/II clinical trial of SYS6055 injection for the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma was officially launched at the first research center in China

Phase II clinical trial of SYH 9061 developed by CSPC Group (01093) to treat idiopathic pulmonary fibrosis was officially launched at the first research center in China

Huaxia Culture Technology (01566): Negotiations are ongoing with several Japanese data center operators on potential leasing and allocation of infrastructure capacity

Lingyue Service Group (02165) intends to acquire land in Sichuan through public tender

Huaxin Construction Materials (06655) plans to acquire 99.99% of the shares of Brazil's National Steel and Cement Company for US$1,642 billion

Tianyu Semiconductor (02658) plans to acquire about 7% of Zhejiang Dongni Electronics shares for 400.1 million yuan

Huaxing Capital Holdings (01911) subsidiary successfully assisted Lingchuan Technology in completing Series B financing of 1 billion yuan

[Buyback/increase or decrease holdings]

On November 6, Sanhuan Group (06951) spent 399 million yuan to buy back 5.4998 million A-shares

Guanghe Technology (01989) spent about 115 million yuan to buy back 1.378,600 A-shares on November 6

COSCO Marine Holdings (01919) spent HK$111 million to buy back 6.3 million shares on November 6

Lanqi Technology (06809) spent 497.531 million yuan to buy back 336,000 A-shares on November 6

Bubble Mart (09992) spent HK$495.44,500 to buy back 350,000 shares on November 6

Luoyang Molybdenum Industry (03993) plans to spend 1 billion yuan to 2 billion yuan to buy back A shares

Ganfeng Lithium (01772): The actual controller and chairman of the company proposed to buy back the company's A shares

Jiangxi Copper Co., Ltd. (00358): The chairman of the company proposed to buy back the company's A shares

Huiju Technology (01729) plans to repurchase shares not exceeding HK$500 million

[Business performance]

Fubo Group (03738)'s total revenue for the third quarter increased by about 32% year-on-year

Guangzhou Automobile Group (02238) sold 143,700 vehicles in October

Yuexiu Real Estate (00123) has accumulated contract sales of about RMB 802.25 billion in the first 10 months

The cumulative contract sales amount of Poly Real Estate Group (00119) in the first 10 months was about 36.6 billion yuan, a year-on-year decrease of 16.44%

Longhu Group (00960) achieved a total contract sales amount of 25.57 billion yuan in the first 10 months

Xuhui Holding Group (00884)'s cumulative contract sales amount for the first 10 months was about 7.77 billion yuan

Baolong Real Estate (01238)'s total contract sales for the first 10 months were about 5.380 billion yuan, a decrease of 13.45% year-on-year

Zhongliang Holdings (02772)'s cumulative contract sales for the first 10 months were about 4.83 billion yuan, a year-on-year decrease of 53.15%

The cumulative contract sales amount of Zhengrong Real Estate (06158) in the first 10 months was about 3.454 billion yuan, a year-on-year decrease of 7.64%

Times China Holdings (01233): October contract sales of about 235 million yuan decreased by 41.69% year on year

The equity power generation capacity of Xiehe New Energy (00182) in October was 665.92 GWh, up 5.05% year-on-year